Company news

IM Cannabis Corp. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

IMC Germany Announces Outstanding Preliminary Q3, 2024 Performance with 50% Growth Over Q2

October 1, 2024

IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors

September 10, 2024

IM Cannabis Reports Second Quarter Financial Results

August 13, 2024

IM Cannabis to Report Second Quarter 2024 Financial Results on Wednesday, August 14th at 9: 00am ET

August 5, 2024

IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement

July 28, 2024

IM Cannabis Shares Commence Trading on 6: 1 Consolidated Basis

July 11, 2024

IM Cannabis Announces Intention to Complete Consolidation

July 4, 2024

IMCC Addresses Accelerated Growth in Germany Through new Supply Agreement with EU-GMP Certified Glasshouse Botanics and Announces a Change to its Board of Directors

June 4, 2024

IM Cannabis Closes Convertible Debenture Offering to Support Accelerated Growth in Germany

May 28, 2024

IM Cannabis to Report First Quarter 2024 Financial Results on Wednesday, May 8th at 9: 00am ET

April 30, 2024

IMC to transfer its Oranim Pharmacy shares back to the seller

April 15, 2024

IM Cannabis Reports 2023 Financial Results

March 27, 2024

IMC Expects Accelerated Growth in Germany from the Country's Groundbreaking Cannabis Legalization

March 24, 2024

IM Cannabis to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 28 at 9: 00am ET

March 19, 2024

IM Cannabis Receives 180 Calendar Day Extension from the Nasdaq Stock Market to Regain Compliance with Bid Price Rule

January 30, 2024

IMC Reschedules the Final Payment of the Oranim Pharmacy Acquisition

January 11, 2024

IMC Announces the Conclusion of the Planning and Construction Legal Proceedings

January 1, 2024

IM Cannabis Announces Receipt of Court Action

November 26, 2023

IM Cannabis Reports Third Quarter 2023 Financial Results

November 12, 2023

IM Cannabis to Report Third Quarter 2023 Financial Results on Monday, November 13 at 9: 00am ET

November 7, 2023

IM Cannabis Announces the appointment of Uri Birenberg as Chief Financial Officer

October 9, 2023

IM Cannabis Reports Second Quarter 2023 Financial Results

August 13, 2023

IMC welcomes new Israeli cannabis regulations which are about to change significantly, facilitating access for many new patients

August 10, 2023

IM Cannabis to Report Second Quarter 2023 Financial Results on Monday, August 14 at 9: 00am ET

August 7, 2023

IM Cannabis Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

August 3, 2023

IM Cannabis Reports First Quarter 2023 Financial Results; Gross Profit Increased 46% Year-over-Year

May 14, 2023

IM Cannabis to Report First Quarter 2023 Financial Results on Monday, May 15 at 9: 00am ET

May 7, 2023

IM Cannabis Completes Debt Settlement with L5 Capital

May 7, 2023

IM Cannabis Announces Units for Debt Settlement

April 27, 2023

IM Cannabis Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Revenues in 2022 Increased 60% Year-over-Year

March 28, 2023

IM Cannabis Announces Additional Restructuring Initiatives Designed to Drive Sustainable Profitability and Reduce Costs

March 7, 2023

IM Cannabis Provides an Update on Panaxia Transaction

February 12, 2023

IM Cannabis Common Shares Commence Trading on Consolidated Basis After 1 for 10 Reverse Stock Split

November 16, 2022

IM Cannabis Reports Third Quarter 2022 Financial Results; Revenues Increased 78% YoY and 12% Sequentially

November 13, 2022

IM Cannabis to Focus on Israel, German and European Growth; Commences Exiting the Canadian Cannabis Market

November 6, 2022

IM Cannabis to Report Third Quarter 2022 Financial Results on Monday, November 14 at 9: 00am ET

October 31, 2022

IM Cannabis's Legacy Strain 'Roma' Voted Israel's Favourite Strain of the Month for August 2022

October 25, 2022

IM Cannabis Closes Second Tranche of Non-Brokered Private Placement of Common Shares

October 5, 2022

IM Cannabis Welcomes Two New Members to its Board of Directors

September 12, 2022

IM Cannabis Reports Record Second Quarter 2022 Financial Results; Revenues Increase 114% YoY to $23.8 Million

August 14, 2022

IM Cannabis to Report Second Quarter 2022 Financial Results on Monday, August 15 at 9: 00am ET

August 3, 2022

IM Cannabis Reports Record First Quarter 2022 Financial Results; Revenues Increase 169% YoY to $23.6 Million

May 11, 2022

IM Cannabis to Report First Quarter 2022 Financial Results on Thursday, May 12 at 5: 00 p.m. ET

May 4, 2022

IM Cannabis Strengthens Focus on Importing Premium and Ultra-Premium Products from its Canadian Subsidiaries

April 5, 2022

IM Cannabis Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results and Provides First Quarter 2022 Outlook

March 30, 2022

IM Cannabis Closes Previously Announced Acquisition of Oranim Pharm, Jerusalem's Leading Medical Cannabis Pharmacy

March 29, 2022

IM Cannabis Reschedules Fourth Quarter and Full Year 2021 Conference Call to Thursday, March 31 at 9: 00 a.m. ET

March 28, 2022

IM Cannabis to Report Fourth Quarter and Full Year 2021 Financial Results on Wednesday, March 30 at 9: 00 a.m. ET

March 22, 2022

IM Cannabis Closes Three Previously Announced Strategic Acquisitions in Israel

March 14, 2022

IM Cannabis Reports Record Preliminary Fourth Quarter and Full Year 2021 Financial Results

March 9, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 14 calls. Every call is listed under its year.

Decks